A physician is reviewing a promotional pamphlet for a newly approved oral hypoglycemic agent. The pamphlet includes a safety summary comparing the incidence of severe hypoglycemic episodes between the new medication and placebo over a 52-week clinical trial period.
The safety data excerpt reports the following:
- Novel Agent Group (): 180 patients experienced at least one episode of severe hypoglycemia.
- Placebo Group (): 112 patients experienced at least one episode of severe hypoglycemia.
Based on the clinical trial data provided in the promotional material, how many patients must be treated with the novel agent instead of placebo for 52 weeks to expect one additional severe hypoglycemic event? (Round your final answer to the nearest whole number).
Answer: 59 patients